These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28520219)

  • 1. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.
    Rabieian R; Boshtam M; Zareei M; Kouhpayeh S; Masoudifar A; Mirzaei H
    J Cell Biochem; 2018 Jan; 119(1):17-27. PubMed ID: 28520219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 in kidney pathology (Review).
    Małgorzewicz S; Skrzypczak-Jankun E; Jankun J
    Int J Mol Med; 2013 Mar; 31(3):503-10. PubMed ID: 23314920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAI-1 in tissue fibrosis.
    Ghosh AK; Vaughan DE
    J Cell Physiol; 2012 Feb; 227(2):493-507. PubMed ID: 21465481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
    Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
    Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.
    Rerolle JP; Hertig A; Nguyen G; Sraer JD; Rondeau EP
    Kidney Int; 2000 Nov; 58(5):1841-50. PubMed ID: 11044203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
    Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
    Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis.
    Flevaris P; Vaughan D
    Semin Thromb Hemost; 2017 Mar; 43(2):169-177. PubMed ID: 27556351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
    Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
    Wang H; Zhang Y; Heuckeroth RO
    FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).
    Suelves M; Vidal B; Ruiz V; Baeza-Raja B; Diaz-Ramos A; Cuartas I; Lluis F; Parra M; Jardi M; Lopez-Alemany R; Serrano AL; Munoz-Canoves P
    Front Biosci; 2005 Sep; 10():2978-85. PubMed ID: 15970552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
    Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
    Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
    Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G
    Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta.
    Hertig A; Berrou J; Allory Y; Breton L; Commo F; Costa De Beauregard MA; Carmeliet P; Rondeau E
    FASEB J; 2003 Oct; 17(13):1904-6. PubMed ID: 12897066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.